Emerging role of tumor-derived extracellular vesicles in T cell suppression and dysfunction in the tumor microenvironment

Immunotherapeutic drugs including immune checkpoint blockade antibodies have been approved to treat patients in many types of cancers. However, some patients have little or no reaction to the immunotherapy drugs. The mechanisms underlying resistance to tumor immunotherapy are complicated and involve...

Descripción completa

Detalles Bibliográficos
Autores principales: Ma, Feiya, Vayalil, Jensen, Lee, Grace, Wang, Yuqi, Peng, Guangyong
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BMJ Publishing Group 2021
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8513270/
https://www.ncbi.nlm.nih.gov/pubmed/34642246
http://dx.doi.org/10.1136/jitc-2021-003217

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8513270/
https://www.ncbi.nlm.nih.gov/pubmed/34642246
http://dx.doi.org/10.1136/jitc-2021-003217

Ejemplares similares